{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:02Z","timestamp":1790677382927,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2051-5960-2-2","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T16:01:24Z","timestamp":1388678484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients"],"prefix":"10.1186","volume":"2","author":[{"given":"Erin J","family":"Feeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Prater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"80_CR1","first-page":"3389","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"R Hirschhorn","year":"2000","unstructured":"Hirschhorn R, Reuser AJ: Glycogen Storage Disease Type II: Acid alpha-Glucosidase (Acid Maltase) Deficiency. In The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 2000:3389\u20133420."},{"key":"80_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Van der Ploeg","year":"2008","unstructured":"Van der Ploeg AT, Reuser AJ: Pompe\u2019s disease. Lancet 2008, 372: 1342\u20131353. 10.1016\/S0140-6736(08)61555-X","journal-title":"Lancet"},{"key":"80_CR3","first-page":"267","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case L, Crowley JF, Downs S, Howell RR, Kravitz RM, et al.: Pompe disease diagnosis and management guideline. GenetMed 2006, 8: 267\u2013288.","journal-title":"GenetMed"},{"key":"80_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","volume":"66","author":"ML Hagemans","year":"2006","unstructured":"Hagemans ML, Hop WJ, Van Doorn PA, Reuser AJ, Van der Ploeg AT: Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 2006, 66: 581\u2013583. 10.1212\/01.wnl.0000198776.53007.2c","journal-title":"Neurology"},{"key":"80_CR5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mus.21025","volume":"38","author":"JH Wokke","year":"2008","unstructured":"Wokke JH, Escolar DM, Pestronk A, Jaffe KM, Carter GT, van den Berg LH, Florence JM, Mayhew J, Skrinar A, Corzo D, Laforet P: Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle & nerve 2008, 38: 1236\u20131245. 10.1002\/mus.21025","journal-title":"Muscle & nerve"},{"key":"80_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, et al.: Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007, 68: 99\u2013109. 10.1212\/01.wnl.0000251268.41188.04","journal-title":"Neurology"},{"key":"80_CR7","first-page":"210","volume":"11","author":"M Nicolino","year":"2009","unstructured":"Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, Arnold GL, Pivnick EK, Ottinger CJ, Robinson PH, et al.: Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. GenetMed 2009, 11: 210\u2013219.","journal-title":"GenetMed"},{"key":"80_CR8","first-page":"329","volume":"66","author":"PS Kishnani","year":"2009","unstructured":"Kishnani PS, Corzo D, Leslie ND, Gruskin D, Van der PA, Clancy JP, Parini R, Morin G, Beck M, Bauer MS, et al.: Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. PediatrRes 2009, 66: 329\u2013335.","journal-title":"PediatrRes"},{"key":"80_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10545-010-9206-3","volume":"33","author":"A Chakrapani","year":"2010","unstructured":"Chakrapani A, Vellodi A, Robinson P, Jones S, Wraith JE: Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience. J Inherit Metab Dis 2010, 33: 747\u2013750. 10.1007\/s10545-010-9206-3","journal-title":"J Inherit Metab Dis"},{"key":"80_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/gim.2012.44","volume":"14","author":"SN Prater","year":"2012","unstructured":"Prater SN, Banugaria SG, DeArmey SM, Botha EG, Stege EM, Case LE, Jones HN, Phornphutkul C, Wang RY, Young SP, Kishnani PS: The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med 2012, 14: 800\u2013810. 10.1038\/gim.2012.44","journal-title":"Genet Med"},{"key":"80_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1750-1172-8-90","volume":"8","author":"SN Prater","year":"2013","unstructured":"Prater SN, Patel TT, Buckley AF, Mandel H, Vlodavski E, Banugaria SG, Feeney EJ, Raben N, Kishnani PS: Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy. Orphanet journal of rare diseases 2013, 8: 90. 10.1186\/1750-1172-8-90","journal-title":"Orphanet journal of rare diseases"},{"key":"80_CR12","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Van der Ploeg","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, et al.: A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. NEnglJMed 2010, 362: 1396\u20131406. 10.1056\/NEJMoa0909859","journal-title":"NEnglJMed"},{"key":"80_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","volume":"107","author":"AT van der Ploeg","year":"2012","unstructured":"van der Ploeg AT, Barohn R, Carlson L, Charrow J, Clemens PR, Hopkin RJ, Kishnani PS, Laforet P, Morgan C, Nations S, et al.: Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa. Mol Genet Metab 2012, 107: 456\u2013461. 10.1016\/j.ymgme.2012.09.015","journal-title":"Mol Genet Metab"},{"key":"80_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","volume":"257","author":"S Strothotte","year":"2010","unstructured":"Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, et al.: Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 2010, 257: 91\u201397. 10.1007\/s00415-009-5275-3","journal-title":"J Neurol"},{"key":"80_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1242\/jcs.01620","volume":"118","author":"DJ Klionsky","year":"2005","unstructured":"Klionsky DJ: The molecular machinery of autophagy: unanswered questions. JCell Sci 2005, 118: 7\u201318. 10.1242\/jcs.01620","journal-title":"JCell Sci"},{"key":"80_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrm2245","volume":"8","author":"DJ Klionsky","year":"2007","unstructured":"Klionsky DJ: Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007, 8: 931\u2013937. 10.1038\/nrm2245","journal-title":"Nat Rev Mol Cell Biol"},{"key":"80_CR17","first-page":"831","volume":"14","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Ahearn M, Roberts A, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N: Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in pompe disease. MolTher 2006, 14: 831\u2013839.","journal-title":"MolTher"},{"key":"80_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4161\/auto.2984","volume":"2","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH, Raben N: Autophagy and lysosomes in Pompe disease. Autophagy 2006, 2: 318\u2013320.","journal-title":"Autophagy"},{"key":"80_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4161\/auto.4591","volume":"3","author":"N Raben","year":"2007","unstructured":"Raben N, Takikita S, Pittis MG, Bembi B, Marie SKN, Roberts A, Page L, Kishnani PS, Schoser BGH, Chien YH, et al.: Deconstructing Pompe disease by analyzing single muscle fibers. Autophagy 2007, 3: 546\u2013552.","journal-title":"Autophagy"},{"key":"80_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymgme.2010.08.001","volume":"101","author":"N Raben","year":"2010","unstructured":"Raben N, Ralston E, Chien YH, Baum R, Schreiner C, Hwu WL, Zaal KJ, Plotz PH: Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy. Mol Genet Metab 2010, 101: 324\u2013331. 10.1016\/j.ymgme.2010.08.001","journal-title":"Mol Genet Metab"},{"key":"80_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/emmm.201202176","volume":"5","author":"C Spampanato","year":"2013","unstructured":"Spampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G, et al.: Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med 2013, 5: 691\u2013706. 10.1002\/emmm.201202176","journal-title":"EMBO Mol Med"},{"key":"80_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4161\/auto.19469","volume":"8","author":"AP Lieberman","year":"2012","unstructured":"Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A: Autophagy in lysosomal storage disorders. Autophagy 2012, 8: 719\u2013730. 10.4161\/auto.19469","journal-title":"Autophagy"},{"key":"80_CR23","first-page":"re1","volume":"2005","author":"DA Gray","year":"2005","unstructured":"Gray DA, Woulfe J: Lipofuscin and aging: a matter of toxic waste. Sci Aging Knowledge Environ 2005, 2005: re1.","journal-title":"Sci Aging Knowledge Environ"},{"key":"80_CR24","first-page":"197","volume":"8","author":"A Terman","year":"2006","unstructured":"Terman A, Brunk UT: Oxidative stress, accumulation of biological 'garbage\u2019, and aging. AntioxidRedoxSignal 2006, 8: 197\u2013204.","journal-title":"AntioxidRedoxSignal"},{"key":"80_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ymgme.2008.09.001","volume":"95","author":"LE Case","year":"2008","unstructured":"Case LE, Koeberl DD, Young SP, Bali D, DeArmey SM, Mackey J, Kishnani PS: Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: a case study. Mol Genet Metab 2008, 95: 233\u2013235. 10.1016\/j.ymgme.2008.09.001","journal-title":"Mol Genet Metab"},{"key":"80_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pediatrneurol.2011.12.010","volume":"46","author":"YH Chien","year":"2012","unstructured":"Chien YH, Lee NC, Huang PH, Lee WT, Thurberg BL, Hwu WL: Early pathologic changes and responses to treatment in patients with later-onset Pompe disease. Pediatr Neurol 2012, 46: 168\u2013171. 10.1016\/j.pediatrneurol.2011.12.010","journal-title":"Pediatr Neurol"},{"key":"80_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0076-6879(08)04021-4","volume":"453","author":"N Raben","year":"2009","unstructured":"Raben N, Shea L, Hill V, Plotz P: Monitoring autophagy in lysosomal storage disorders. Methods Enzymol 2009, 453: 417\u2013449.","journal-title":"Methods Enzymol"},{"key":"80_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18632\/aging.100527","volume":"5","author":"EA Georgakopoulou","year":"2013","unstructured":"Georgakopoulou EA, Tsimaratou K, Evangelou K, Fernandez Marcos PJ, Zoumpourlis V, Trougakos IP, Kletsas D, Bartek J, Serrano M, Gorgoulis VG: Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging 2013, 5: 37\u201350.","journal-title":"Aging"},{"key":"80_CR29","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.yexcr.2006.04.014","volume":"312","author":"K Yamanouchi","year":"2006","unstructured":"Yamanouchi K, Yada E, Ishiguro N, Hosoyama T, Nishihara M: Increased adipogenicity of cells from regenerating skeletal muscle. Exp Cell Res 2006, 312: 2701\u20132711. 10.1016\/j.yexcr.2006.04.014","journal-title":"Exp Cell Res"},{"key":"80_CR30","first-page":"500","volume":"162","author":"E Ralston","year":"2008","unstructured":"Ralston E, Swaim B, Czapiga M, Hwu WL, Chien YH, Pittis MG, Bembi B, Schwartz O, Plotz P, Raben N: Detection and imaging of non-contractile inclusions and sarcomeric anomalies in skeletal muscle by second harmonic generation combined with two-photon excited fluorescence. JStructBiol 2008, 162: 500\u2013508.","journal-title":"JStructBiol"},{"key":"80_CR31","first-page":"19086","volume":"273","author":"N Raben","year":"1998","unstructured":"Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L, LaMarca M, King C, Ward J, Sauer B, Plotz P: Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. JBiolChem 1998, 273: 19086\u201319092.","journal-title":"JBiolChem"},{"key":"80_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/ars.2009.2598","volume":"12","author":"A Terman","year":"2010","unstructured":"Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT: Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010, 12: 503\u2013535. 10.1089\/ars.2009.2598","journal-title":"Antioxid Redox Signal"},{"key":"80_CR33","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1167\/iovs.11-8970","volume":"53","author":"D Schweitzer","year":"2012","unstructured":"Schweitzer D, Gaillard ER, Dillon J, Mullins RF, Russell S, Hoffmann B, Peters S, Hammer M, Biskup C: Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen. Invest Ophthalmol Vis Sci 2012, 53: 3376\u20133386. 10.1167\/iovs.11-8970","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"80_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0891-5849(02)00959-0","volume":"33","author":"UT Brunk","year":"2002","unstructured":"Brunk UT, Terman A: Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free RadicBiolMed 2002, 33: 611\u2013619.","journal-title":"Free RadicBiolMed"},{"key":"80_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1474-9726.2007.00282.x","volume":"6","author":"E Hutter","year":"2007","unstructured":"Hutter E, Skovbro M, Lener B, Prats C, Rabol R, Dela F, Jansen-Durr P: Oxidative stress and mitochondrial impairment can be separated from lipofuscin accumulation in aged human skeletal muscle. Aging Cell 2007, 6: 245\u2013256. 10.1111\/j.1474-9726.2007.00282.x","journal-title":"Aging Cell"},{"key":"80_CR36","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nbt894","volume":"21","author":"PJ Campagnola","year":"2003","unstructured":"Campagnola PJ, Loew LM: Second-harmonic imaging microscopy for visualizing biomolecular arrays in cells, tissues and organisms. Nat Biotechnol 2003, 21: 1356\u20131360. 10.1038\/nbt894","journal-title":"Nat Biotechnol"},{"key":"80_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1529\/biophysj.105.071555","volume":"90","author":"SV Plotnikov","year":"2006","unstructured":"Plotnikov SV, Millard AC, Campagnola PJ, Mohler WA: Characterization of the myosin-based source for second-harmonic generation from muscle sarcomeres. Biophysical journal 2006, 90: 693\u2013703. 10.1529\/biophysj.105.071555","journal-title":"Biophysical journal"},{"key":"80_CR38","first-page":"2231","volume":"3","author":"ML Huie","year":"1994","unstructured":"Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R: Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13\u00a0T\u2192G) mutation in a majority of patients and a novel IVS10 (+1GT\u2192CT) mutation. HumMolGenet 1994, 3: 2231\u20132236.","journal-title":"HumMolGenet"},{"key":"80_CR39","first-page":"995","volume":"5","author":"N Raben","year":"1996","unstructured":"Raben N, Nichols RC, Martiniuk F, Plotz PH: A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II). HumMolGenet 1996, 5: 995\u20131000.","journal-title":"HumMolGenet"},{"key":"80_CR40","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1542\/peds.2007-2222","volume":"122","author":"YH Chien","year":"2008","unstructured":"Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, Chen CA, Wu MH, Huang PH, Tsai FJ, et al.: Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics 2008, 122: e39-e45. 10.1542\/peds.2007-2222","journal-title":"Pediatrics"},{"key":"80_CR41","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","volume":"124","author":"YH Chien","year":"2009","unstructured":"Chien YH, Lee NC, Thurberg BL, Chiang SC, Zhang XK, Keutzer J, Huang AC, Wu MH, Huang PH, Tsai FJ, et al.: Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics 2009, 124: e1116-e1125. 10.1542\/peds.2008-3667","journal-title":"Pediatrics"},{"key":"80_CR42","first-page":"63","volume":"53","author":"CM Lynch","year":"2005","unstructured":"Lynch CM, Johnson J, Vaccaro C, Thurberg BL: High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology. JHistochemCytochem 2005, 53: 63\u201373.","journal-title":"JHistochemCytochem"},{"key":"80_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/gim.2011.4","volume":"14","author":"YH Messinger","year":"2012","unstructured":"Messinger YH, Mendelsohn NJ, Rhead W, Dimmock D, Hershkovitz E, Champion M, Jones SA, Olson R, White A, Wells C, et al.: Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease. Genet Med 2012, 14: 135\u2013142. 10.1038\/gim.2011.4","journal-title":"Genet Med"},{"key":"80_CR44","first-page":"5","volume":"1","author":"J Vissing","year":"2013","unstructured":"Vissing J, Lukacs Z, Straub V: Diagnosis of Pompe Disease: Muscle Biopsy vs Blood-Based Assays. JAMA Neurol 2013, 1: 5.","journal-title":"JAMA Neurol"},{"key":"80_CR45","first-page":"45","volume":"26","author":"N Raben","year":"2007","unstructured":"Raben N, Roberts A, Plotz PH: Role of Autophagy in the Pathogenesis of Pompe Disease. Acta Myol 2007, 26: 45\u201348.","journal-title":"Acta Myol"},{"key":"80_CR46","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","volume":"6","author":"N Raben","year":"2010","unstructured":"Raben N, Schreiner C, Baum R, Takikita S, Xu S, Xie T, Myerowitz R, Komatsu M, Van Der Meulen JH, Nagaraju K, et al.: Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease. Autophagy 2010, 6: 1078\u20131089. 10.4161\/auto.6.8.13378","journal-title":"Autophagy"},{"key":"80_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajmg.c.31317","volume":"160","author":"N Raben","year":"2012","unstructured":"Raben N, Wong A, Ralston E, Myerowitz R: Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Am J Med Genet C: Semin Med Genet 2012, 160: 13\u201321.","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"80_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF00304641","volume":"85","author":"V Jay","year":"1992","unstructured":"Jay V, Christodoulou J, Mercer-Connolly A, McInnes RR: \u201cReducing body\u201d-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency. Acta neuropathologica 1992, 85: 111\u2013115. 10.1007\/BF00304641","journal-title":"Acta neuropathologica"},{"key":"80_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00401-005-1026-4","volume":"110","author":"MC Sharma","year":"2005","unstructured":"Sharma MC, Schultze C, Von Moers A, Stoltenburg-Didinger G, Shin YS, Podskarbi T, Isenhardt K, Tews DS, Goebel HH: Delayed or late-onset type II glycogenosis with globular inclusions. Acta Neuropathol Berl 2005, 110: 151\u2013157. 10.1007\/s00401-005-1026-4","journal-title":"Acta Neuropathol Berl"},{"key":"80_CR50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","volume":"33","author":"BG Schoser","year":"2007","unstructured":"Schoser BG, Muller-Hocker J, Horvath R, Gempel K, Pongratz D, Lochmuller H, Muller-Felber W: Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 2007, 33: 544\u2013559.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"80_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nmd.2011.11.003","volume":"22","author":"RS Tsuburaya","year":"2012","unstructured":"Tsuburaya RS, Monma K, Oya Y, Nakayama T, Fukuda T, Sugie H, Hayashi YK, Nonaka I, Nishino I: Acid phosphatase-positive globular inclusions is a good diagnostic marker for two patients with adult-onset Pompe disease lacking disease specific pathology. Neuromuscular disorders : NMD 2012, 22: 389\u2013393. 10.1016\/j.nmd.2011.11.003","journal-title":"Neuromuscular disorders : NMD"},{"key":"80_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1749-6632.2002.tb02083.x","volume":"959","author":"EA Porta","year":"2002","unstructured":"Porta EA: Pigments in aging: an overview. Ann N Y Acad Sci 2002, 959: 57\u201365.","journal-title":"Ann N Y Acad Sci"},{"key":"80_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cbi.2006.04.013","volume":"163","author":"A Terman","year":"2006","unstructured":"Terman A, Gustafsson B, Brunk UT: The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 2006, 163: 29\u201337. 10.1016\/j.cbi.2006.04.013","journal-title":"Chem Biol Interact"},{"key":"80_CR54","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1078\/0171-9335-00433","volume":"83","author":"Y Stroikin","year":"2004","unstructured":"Stroikin Y, Dalen H, Loof S, Terman A: Inhibition of autophagy with 3-methyladenine results in impaired turnover of lysosomes and accumulation of lipofuscin-like material. Eur J Cell Biol 2004, 83: 583\u2013590. 10.1078\/0171-9335-00433","journal-title":"Eur J Cell Biol"},{"key":"80_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/01913129809032266","volume":"22","author":"T Yoshihara","year":"1998","unstructured":"Yoshihara T, Ishii T, Iwata M, Nomoto M: Ultrastructural and histochemical study of the motor end plates of the intrinsic laryngeal muscles in amyotrophic lateral sclerosis. Ultrastruct Pathol 1998, 22: 121\u2013126. 10.3109\/01913129809032266","journal-title":"Ultrastruct Pathol"},{"key":"80_CR56","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.bbadis.2013.01.019","volume":"1832","author":"K Kollmann","year":"2013","unstructured":"Kollmann K, Uusi-Rauva K, Scifo E, Tyynela J, Jalanko A, Braulke T: Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta 2013, 1832: 1866\u20131881. 10.1016\/j.bbadis.2013.01.019","journal-title":"Biochim Biophys Acta"},{"key":"80_CR57","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1111\/febs.12142","volume":"280","author":"JR Terrill","year":"2013","unstructured":"Terrill JR, Radley-Crabb HG, Iwasaki T, Lemckert FA, Arthur PG, Grounds MD: Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. Febs J 2013, 280: 4149\u20134164. 10.1111\/febs.12142","journal-title":"Febs J"},{"key":"80_CR58","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1369\/0022155411412185","volume":"59","author":"H Tohma","year":"2011","unstructured":"Tohma H, Hepworth AR, Shavlakadze T, Grounds MD, Arthur PG: Quantification of ceroid and lipofuscin in skeletal muscle. J Histochem Cytochem 2011, 59: 769\u2013779. 10.1369\/0022155411412185","journal-title":"J Histochem Cytochem"},{"key":"80_CR59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/mus.10039","volume":"25","author":"J Allaire","year":"2002","unstructured":"Allaire J, Maltais F, LeBlanc P, Simard PM, Whittom F, Doyon JF, Simard C, Jobin J: Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 2002, 25: 383\u2013389. 10.1002\/mus.10039","journal-title":"Muscle Nerve"},{"key":"80_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1023\/B:HIJO.0000045947.83628.a7","volume":"35","author":"Y Nakae","year":"2004","unstructured":"Nakae Y, Stoward PJ, Kashiyama T, Shono M, Akagi A, Matsuzaki T, Nonaka I: Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice. Journal of molecular histology 2004, 35: 489\u2013499.","journal-title":"Journal of molecular histology"},{"key":"80_CR61","first-page":"3897","volume":"17","author":"N Raben","year":"2008","unstructured":"Raben N, Hill V, Shea L, Takikita S, Baum R, Mizushima N, Ralston E, Plotz P: Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. HumMolGenet 2008, 17: 3897\u20133908.","journal-title":"HumMolGenet"},{"key":"80_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2005.8.3","volume":"8","author":"JJ Lemasters","year":"2005","unstructured":"Lemasters JJ: Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 2005, 8: 3\u20135. 10.1089\/rej.2005.8.3","journal-title":"Rejuvenation Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2051-5960-2-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:51:24Z","timestamp":1716382284000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-2-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-2-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]},"assertion":[{"value":"29 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}